TVRD

Tvardi Therapeutics, Inc. Common Stock
TVRD

Overview Fund Activity

95 hedge funds and large institutions have $341M invested in Tvardi Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
95
Holders Change
+3
Holders Change %
+3.26%
% of All Funds
2.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
16
Increased
37
Reduced
28
Closed
13
Calls
$387K
Puts
$19K
Net Calls
+$368K
Net Calls Change
+$88K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$8.52M
2
EAM
EverPoint Asset Management
Connecticut
+$7.59M
3
Allianz Asset Management
Allianz Asset Management
Germany
+$4.26M
4
PCA
Private Capital Advisors
Connecticut
+$4.16M
5
SAM
Sectoral Asset Management
Quebec, Canada
+$3.19M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$3.44M
2
BIM
Bogle Investment Management
Massachusetts
-$2.04M
3
WSA
Wall Street Associates
California
-$2M
4
SGAM
Smith Group Asset Management
Texas
-$1.63M
5
ARTA
A.R.T. Advisors
New York
-$1.36M
Name Holding Trade Value Shares
Change 		Shares
Change %
GGHC
101
Gilder Gagnon Howe & Co
New York
– -$399K -776 Closed
ICAP
102
Independence Capital Asset Partners
Colorado
– -$320K -621 Closed
Two Sigma Advisers
103
Two Sigma Advisers
New York
– -$273K -519 Closed
CS
104
Credit Suisse
Switzerland
– -$143K -278 Closed
Group One Trading
105
Group One Trading
Illinois
– -$32K -63 Closed
Walleye Trading
106
Walleye Trading
New York
– -$19K -36 Closed
MA
107
MUFG Americas
New York
– -$1K -3 Closed
1 2 3 4
5